comparemela.com

Rhenman & Partners Asset Management AB grew its stake in Mirati Therapeutics, Inc. (NASDAQ:MRTX – Free Report) by 25.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 175,000 shares of the biotechnology company’s stock after purchasing an additional 35,000 shares during […]

Related Keywords

United States ,Leerink Partnrs ,Stifel Nicolaus ,Benjamin Hickey ,Jamie Christensen ,Exchange Commission ,Advisor Group Holdings Inc ,Mirati Therapeutics Inc ,Headlands Technologies ,Citigroup ,Nasdaq ,First Horizon Advisors Inc ,Bluepath Capital Management ,Securities Exchange Commission ,Partners Asset Management ,Mirati Therapeutics ,Free Report ,Horizon Advisors ,Path Capital Management ,Advisor Group Holdings ,Group Holdings ,Therapeutics Trading Down ,Visit Holdingschannel ,Mirati Therapeutics Daily ,Nasdaq Mrtx ,Mrtx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.